Litcius/Paper detail

A combinatorial delivery of survivin targeted siRNA using cancer selective nanoparticles for triple negative breast cancer therapy

Prashant Kesharwani, Afsana Sheikh, Mohammed A. S. Abourehab, Rajesh Salve, Virendra Gajbhiye

2023Journal of Drug Delivery Science and Technology62 citationsDOI

Topics & Concepts

SurvivinTriple-negative breast cancerCancer researchDoxorubicinBreast cancerCancerCancer cellEstrogen receptorTargeted therapyNanocarriersGene silencingChemistryMedicineChemotherapyPharmacologyDrugInternal medicineBiochemistryGeneRNA Interference and Gene DeliveryAdvanced biosensing and bioanalysis techniquesDendrimers and Hyperbranched Polymers
A combinatorial delivery of survivin targeted siRNA using cancer selective nanoparticles for triple negative breast cancer therapy | Litcius